Effect of ethinyl estradiol treatment on lipoproteins and LCAT activity in aged rats.
The induction of hepatic lipoprotein (apo B/E) have been investigated in Fischer-344 rats. These studies were aimed to determine the mechanism underlying the previously observed (Lee et al., Mech. Ageing Dev., 61 (1991) 85-98) hypercholesterolemia and the age-related decrease in the fractional rate of endogenous cholesterol esterification. Young (5 months) and aged (22 months) male Fischer-344 rats were treated with pharmacological doses (5 mg/kg per day) of ethinyl estradiol (EE) for 7 days. Reduction of plasma cholesterol (57% in young vs 47% in aged rats) and high density lipoprotein cholesterol (64% in young vs 63% in aged rats) occurred in both groups upon EE treatment. Initial low density lipoprotein levels were very low in the plasma of young rats and consequently were not affected by EE treatment. However, in aged rats, the low density lipoprotein levels were much higher initially and were markedly reduced by EE treatment. (18.0 vs 10.0 mg/dl). Very low density lipoproteins were about the same initially but increased in aged rats and decreased in young rats upon EE treatment. Both the lecithin:cholesterol acyltransferase (LCAT) activity (as determined with a proteoliposome substrate) and the fractional rate (FR) of the endogenous cholesterol esterification decreased in treated animals compared to controls. However, the differences in the FR of the endogenous cholesterol esterification between young and aged rats (observed before treatment) were nearly abolished upon treatment. These data suggest that the previously observed age related decrease in the FR of endogenous cholesterol esterification is due to the accumulation of apolipoprotein E-rich (apo E) lipoproteins.(ABSTRACT TRUNCATED AT 250 WORDS)
Lee
S M
SM
Department of Biochemistry, Texas College of Osteopathic Medicine, University of North Texas, Fort Worth 76107.
Kudchodkar
B J
BJ
Lacko
A G
AG
D000375:Aging / Q000097:blood* / Q000378:metabolism; D000818:Animals; D001057:Apolipoproteins E / Q000097:blood; D002788:Cholesterol Esters / Q000097:blood; D004997:Ethinyl Estradiol / Q000494:pharmacology*; D008074:Lipoproteins / Q000097:blood* / Q000378:metabolism; D008075:Lipoproteins, HDL / Q000097:blood; D008099:Liver / Q000187:drug effects / Q000378:metabolism; D008297:Male; D009929:Organ Size / Q000187:drug effects; D007862:Phosphatidylcholine-Sterol O-Acyltransferase / Q000097:blood*; D051381:Rats; D011916:Rats, Inbred F344
D001057:Apolipoproteins E; D002788:Cholesterol Esters; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D004997:Ethinyl Estradiol; D007862:Phosphatidylcholine-Sterol O-Acyltransferase